KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Dividends Paid - Common (2017 - 2020)

Biogen (BIIB) has 8 years of Dividends Paid - Common data on record, last reported at -$66.3 million in Q4 2020.

  • For Q4 2020, Dividends Paid - Common fell 1641.86% year-over-year to -$66.3 million; the TTM value through Sep 2021 reached $8.9 million, down 76.76%, while the annual FY2020 figure was $4.6 million, N/A changed from the prior year.
  • Dividends Paid - Common reached -$66.3 million in Q4 2020 per BIIB's latest filing, down from $70.9 million in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $302.7 million in Q1 2017 and bottomed at -$66.3 million in Q4 2020.
  • Average Dividends Paid - Common over 4 years is $46.1 million, with a median of $4.3 million recorded in 2019.
  • Peak YoY movement for Dividends Paid - Common: skyrocketed 111.65% in 2019, then crashed 1641.86% in 2020.
  • A 4-year view of Dividends Paid - Common shows it stood at $302.7 million in 2017, then crashed by 112.19% to -$36.9 million in 2018, then skyrocketed by 111.65% to $4.3 million in 2019, then plummeted by 1641.86% to -$66.3 million in 2020.
  • Per Business Quant database, its latest 3 readings for Dividends Paid - Common were -$66.3 million in Q4 2020, $70.9 million in Q3 2020, and $4.3 million in Q4 2019.